Some observations on the behavioural effects of hallucinogenic drugs on rats: potentiation by two drugs affecting monoamine metabolism.
D000588:Amines / Q000378:metabolism; D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects; D001522:Behavior, Animal / Q000187:drug effects*; D001921:Brain / Q000378:metabolism; D003213:Conditioning, Psychological / Q000187:drug effects; D003517:Cyclopentanes / Q000494:pharmacology; D004192:Discrimination, Psychological / Q000187:drug effects; D004357:Drug Synergism; D005260:Female; D006213:Hallucinogens / Q000494:pharmacology*; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D008297:Male; D008333:Mandelic Acids / Q000494:pharmacology; D008635:Mescaline / Q000494:pharmacology; D008781:Methyltyrosines / Q000494:pharmacology; D008784:Methysergide / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D010622:Phencyclidine / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains
D000588:Amines; D003517:Cyclopentanes; D006213:Hallucinogens; D008333:Mandelic Acids; D008781:Methyltyrosines; D010880:Piperidines; D008238:Lysergic Acid Diethylamide; D010622:Phencyclidine; D008635:Mescaline; D008784:Methysergide